Brief: Cipher Pharmaceuticals reports Q3 2016 financial results

Cipher Pharmaceuticals

11/11/2016 12:02

Nov 11 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO  
    * Cipher Pharmaceuticals reports Q3 2016 financial results 
    * Cipher Pharmaceuticals Inc says Q3  total revenue of $9.3 
million, an increase of 10% from $8.5 million in Q3 2015 
    * Cipher Pharmaceuticals Inc says Q3 licensing revenue of 
$6.8 million, an increase of 9% over $6.3 million in Q3 2015 
    * Qtrly net loss of $21.8 million, or $0.81 per basic share, 
    * Excluding impairment charge, qtrly net loss would have 
been $2.2 million, or $0.08 per basic share 
    * Cipher Pharmaceuticals Inc - Incurred a non-cash 
impairment charge on intangible assets of $17.3 million, 
goodwill of $2.3 million related to U.S. Segment in quarter 
 
Source text for Eikon:  ID:nPnb0dzr7a  
Further company coverage:  CPH.TO  
 
 ((Bangalore.newsroom@thomsonreuters.com;))